OXFORD BIOMEDICA

Oxford BioMedica plc has launched a new website at: http://www.oxfordbiomedica.co.uk

The updated site carries information on the Company's gene therapy programmes, key product and technology areas, new facilities, financial reports and news releases.

Notes to Editors:

1. Oxford BioMedica, established in 1995, specialises in the development and application of gene-based therapeutics using advanced viral gene delivery technologies for the treatment of disease in the areas of cancer, viral infection, neurodegenerative diseases and genetic deficiency. Oxford BioMedica plc was floated on the UK Alternative Investment Market of the London Stock Exchange in December 1996.